⚠️ RESEARCH USE ONLY - NOT FOR HUMAN CONSUMPTION - NOT APPROVED BY MHRA - 18+ ONLY

Verified Peptides

ARA-290 Research & Scientific Studies

Explore the latest peer-reviewed research and scientific studies

About ARA-290

ARA-290 is a synthetic peptide derived from erythropoietin (EPO), designed in research contexts to engage EPO-related tissue-protective signaling without erythropoiesis-focused activity. Supplied as a lyophilized powder for laboratory investigations into inflammatory signaling markers, cellular stress-response pathways, and tissue-protection-associated mechanisms. Each batch is verified for identity and purity using HPLC and mass spectrometry. Supplied as: Lyophilized powder Purity: 99%+ (HPLC verified) Storage: Store desiccated at ?20�C for long-term. Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light. Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.

Purity99
Categorypeptide

Latest Research

Featured Study

Anti-Inflammatory Effects of Clarstatin, a Shared-Epitope-Antagonistic Cyclic Peptide, on Experimental Autoimmune Uveitis in Mice.

Merzbach S et al.Invest Ophthalmol Vis Sci2025

Recent research on ARA-290: Anti-Inflammatory Effects of Clarstatin, a Shared-Epitope-Antagonistic Cyclic Peptide, on Experimental Autoimmune Uveitis in Mice.

Read Full Study on PubMed
Featured Study

Phase-targeted erythropoietin derivatives for traumatic brain injury: bridging mechanisms to precision therapy.

Sun Y et al.Front Neurol2025

Recent research on ARA-290: Phase-targeted erythropoietin derivatives for traumatic brain injury: bridging mechanisms to precision therapy.

Read Full Study on PubMed

Additional Studies

The protective effect of erythropoietin and its novel derived peptides in peripheral nerve injury.

Liu G et al.Int Immunopharmacol2024

Recent research on ARA-290: The protective effect of erythropoietin and its novel derived peptides in peripheral nerve injury.

Read on PubMed

Erythropoietin-derived peptide ARA290 mediates brain tissue protection through the β-common receptor in mice with cerebral ischemic stroke.

Wang RL et al.CNS Neurosci Ther2024

Recent research on ARA-290: Erythropoietin-derived peptide ARA290 mediates brain tissue protection through the β-common receptor in mice with cerebral ischemic stroke.

Read on PubMed

Related Research

Purchase ARA-290 from Verified Peptides

High-purity research peptides with full analytical verification

  • 99% Purity (HPLC Verified)
  • Full Certificate of Analysis
  • Same Day Dispatch
  • Free UK Shipping Over £75
Buy ARA-290 - 99% Purity, Same Day Dispatch

Research Disclaimer

The research articles and studies referenced on this page are for informational purposes only. All products are sold for research use only and are not intended for human or animal consumption. The information provided does not constitute medical advice, diagnosis, or treatment. Always consult with qualified healthcare professionals before making any decisions related to health or medical treatment.